FindTrial
Sign In

Comparison efficacy for termination of early pregnancy failure by mifepristone followed by misoprostol with misoprostol alone : A Randomized Double-Blind Placebo- Controlled Trial

Comparision efficacy for termination of early pregnancy failure by misoprostol with misoprostol alone : A Randomized Double&#45; Blind Placebo&#45;Controlled trial &#45;evaluated by ultrasound for ET keep < 0.5 cm

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180825005
Enrollment
Unknown
Registered
2018-08-25
Start date
2018-07-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy failure pregnancy failure

Interventions

comparison of different regimen for termination of pregnancy failure Arm1>>mifepristone then followed by misoprostal,comparison of different regimen for termination of pregnancy failure Arm2>>misopros
Active Comparator Drug,Placebo Comparator Drug
mifepristone then followed by misoprostal,misoprostal only

Sponsors

none
Lead Sponsor
none,none
Collaborator

Eligibility

Sex/Gender
Female
Age
15 Years to 50 Years

Inclusion criteria

Inclusion criteria: &#45;pregnancy GA < 12 wk &#45;pregnancy failure &#45;vital sign stable &#45;accepted to follow this research

Exclusion criteria

Exclusion criteria: &#45;inevitable or incomplete abortion &#45;vital sign unstable &#45;Hemoglobin < 8 mg% &#45;coagulopathy &#45;suspected sepsis &#45;history of mifepristone or misoprostal allergy

Design outcomes

Primary

MeasureTime frame
complete abortion 2 day after intervention[ cytotec vaginal suppository] trans vaginal ultrasound for evaluate endometrial thickness [ET] and blind operator& participant—

Secondary

MeasureTime frame
satisfaction of patient 2 day after intervention[ cytotec vaginal suppository] Patient reported outcome using a questionnaire interview—

Countries

Thailand

Contacts

Public ContactNattaya Sawanwattanaku

BHUMIBHOL ADULYADEJ HOSPITAL

Sawanwattanaku@gmail.com089-0168460

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026